Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21320474rdf:typepubmed:Citationlld:pubmed
pubmed-article:21320474lifeskim:mentionsumls-concept:C1512035lld:lifeskim
pubmed-article:21320474lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:21320474pubmed:dateCreated2011-3-28lld:pubmed
pubmed-article:21320474pubmed:abstractTextZonisamide is an antiepileptic drug that also improves the cardinal symptoms of Parkinson's disease. This study investigated the effects of zonisamide on dopaminergic neuronal degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Six groups of mice were treated as follows: 1) normal saline; 2) MPTP, 15 mg/kg×4 every 2h; 3) MPTP and zonisamide, 40 mg/kg×1, 1h after the last MPTP dose; 4) MPTP and zonisamide, 1 day after the last dose of MPTP; 5) MPTP and zonisamide, 1h before the first MPTP dose; and 6) zonisamide, 40 mg/kg. MPTP-treatment decreased the contents of dopamine as well as the number and area of tyrosine hydroxylase (TH)-positive neurons. Concurrent treatment of mice with zonisamide and MPTP did not show any inhibition of the toxic effect of MPTP towards dopamine contents at 1 week after treatment but it increased the number and area of TH-positive neurons compared to the MPTP-treated group. Surviving TH-positive neurons had recovery of dopamine production after several weeks. Moreover, zonisamide increased the number of S100?-positive and glial fibrillary acidic protein (GFAP)-positive astrocytes and dopamine turnover. These results suggest that zonisamide acts as a neuro-protectant against MPTP-induced dopaminergic neuronal degeneration as shown by an increase of TH-positive neurons and this may be mediated by increased S100? secretion.lld:pubmed
pubmed-article:21320474pubmed:languageenglld:pubmed
pubmed-article:21320474pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:citationSubsetIMlld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21320474pubmed:statusMEDLINElld:pubmed
pubmed-article:21320474pubmed:monthAprlld:pubmed
pubmed-article:21320474pubmed:issn1872-6240lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:NagaiMasahiro...lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:MoritoyoTakas...lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:MatsudaSeijiSlld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:NomotoMasahir...lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:NishikawaNori...lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:YabeHayatoHlld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:KuboMadokaMlld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:ChoudhuryMoha...lld:pubmed
pubmed-article:21320474pubmed:authorpubmed-author:KyawWin...lld:pubmed
pubmed-article:21320474pubmed:copyrightInfoCopyright © 2011 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21320474pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21320474pubmed:day12lld:pubmed
pubmed-article:21320474pubmed:volume1384lld:pubmed
pubmed-article:21320474pubmed:ownerNLMlld:pubmed
pubmed-article:21320474pubmed:authorsCompleteYlld:pubmed
pubmed-article:21320474pubmed:pagination170-8lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:meshHeadingpubmed-meshheading:21320474...lld:pubmed
pubmed-article:21320474pubmed:year2011lld:pubmed
pubmed-article:21320474pubmed:articleTitleZonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity.lld:pubmed
pubmed-article:21320474pubmed:affiliationDepartment of Therapeutic Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon-Shi, Ehime 791-0295, Japan.lld:pubmed
pubmed-article:21320474pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21320474pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed